A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

This study has been completed.

Study NCT00236691 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: October 7, 2005 Last Updated: June 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 1990
Estimated Primary Completion Date:	No date given